Balaxi Pharmaceuticals Limited Conducts Groundbreaking Ceremony for its Upcoming Rs. 85 Cr. State-of-the-Art Manufacturing Facility in Hyderabad
Commissioning of the US-FDA, EU-GMP, WHO-Geneva Compliant Pharmaceutical Formulation facility is scheduled for March 2024 The unit will be equipped with cutting-edge technology that enables greater energy efficiency NSE listed Balaxi Pharmaceuticals Limited, a leading ....